DOI: 10.11958/20240783
Tianjin expert consensus on the prevention and treatment of refractory chemotherapy-related nausea and vomiting(2025 edition)
Tianjin Anti-Cancer Association Committee of Rehabilitation and Palliative Care
Tianjin Medical Doctor Association Committee of Tumor Multidisciplinary Diagnosis and Treatment
ZHANG Linlin
Abstract：Nausea and vomiting are the most common adverse reactions of chemotherapy.In recent years,with the progression of palliative and supportive care,the prevention and control rate of chemotherapy induced nausea and vomiting(CINV)have been effectively improved.However,a small number of CINV still cannot be controlled satisfactorily or recurrence after receiving CINV prevention and treatments,which gradually develops into refractory CINV.Refractory CINV is a very difficult problem in the field of supportive care,which seriously affects the quality of life of patients,chemotherapy progress and prognosis.Therefore,Tianjin Anti-Cancer Association Committee of Rehabilitation and Palliative Care and Tianjin Medical Doctor Association Committee of Tumor Multidisciplinary Diagnosis and Treatment(MDT)organized experts to formulate a Tianjin expert consensus on the prevention and treatment of refractory CINV.The concept of refractory CINV,prevention and treatment strategies,specific medication guidance,traditional Chinese medical treatments,nursing and MDT management are summarized.Meanwhile,the corresponding recommendations are also given in order to provide more reference for improving the prevention and treatment of refractory CINV.This consensus only provides academic guidance for refractory CINV,the specific implementation plans need to be determined based on actual clinical conditions.
Keywords：nauseavomitingrefractory nausea and vomitingchemotherapy induced nausea and vomitingprevention and treatmentconsensus
Publication Date：2025-01-14
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：8( 1-8 )